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Acute cardiovascular effects of controlled
exposure to dilute Petrodiesel and
biodiesel exhaust in healthy volunteers: a
crossover study
Jon Unosson1,2, Mikael Kabéle1, Christoffer Boman3, Robin Nyström3, Ioannis Sadiktsis4, Roger Westerholm4,
Ian S. Mudway5, Esme Purdie5, Jennifer Raftis6, Mark R. Miller7, Nicholas L. Mills7,8, David E. Newby7,
Anders Blomberg1, Thomas Sandström1,9* and Jenny A. Bosson1
Abstract
Background: Air pollution derived from combustion is associated with considerable cardiorespiratory morbidity
and mortality in addition to environmental effects. Replacing petrodiesel with biodiesel may have ecological
benefits, but impacts on human health remain unquantified.
The objective was to compare acute cardiovascular effects of blended and pure biodiesel exhaust exposure against
known adverse effects of petrodiesel exhaust (PDE) exposure in human subjects.
In two randomized controlled double-blind crossover studies, healthy volunteers were exposed to PDE or biodiesel
exhaust for one hour. In study one, 16 subjects were exposed, on separate occasions, to PDE and 30% rapeseed
methyl ester biodiesel blend (RME30) exhaust, aiming at PM10 300 μg/m3. In study two, 19 male subjects were
separately exposed to PDE and exhaust from a 100% RME fuel (RME100) using similar engine load and exhaust
dilution. Generated exhaust was analyzed for physicochemical composition and oxidative potential. Following
exposure, vascular endothelial function was assessed using forearm venous occlusion plethysmography and ex vivo
thrombus formation was assessed using a Badimon chamber model of acute arterial injury. Biomarkers of
inflammation, platelet activation and fibrinolysis were measured in the blood.
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Results: In study 1, PDE and RME30 exposures were at comparable PM levels (314 ± 27 μg/m3; (PM10 ± SD) and
309 ± 30 μg/m3 respectively), whereas in study 2, the PDE exposure concentrations remained similar (310 ± 34 μg/
m3), but RME100 levels were lower in PM (165 ± 16 μg/m3) and PAHs, but higher in particle number concentration.
Compared to PDE, PM from RME had less oxidative potential. Forearm infusion of the vasodilators acetylcholine,
bradykinin, sodium nitroprusside and verapamil resulted in dose-dependent increases in blood flow after all
exposures. Vasodilatation and ex vivo thrombus formation were similar following exposure to exhaust from
petrodiesel and the two biodiesel formulations (RME30 and RME100). There were no significant differences in blood
biomarkers or exhaled nitric oxide levels between exposures.
Conclusions: Despite differences in PM composition and particle reactivity, controlled exposure to biodiesel
exhaust was associated with similar cardiovascular effects to PDE. We suggest that the potential adverse health
effects of biodiesel fuel emissions should be taken into account when evaluating future fuel policies.
Trial registration: ClinicalTrials.gov, NCT01337882/NCT01883466. Date of first enrollment March 11, 2011, registered
April 19, 2011, i.e. retrospectively registered.
Keywords: Air pollution, Particulate matter, Diesel, Biodiesel, Cardiovascular system, Vascular function, Vasomotor
dysfunction, Thrombosis, Endothelial function
Background
Particulate matter air pollution (PM) has a well-established
and consistent association with cardiovascular and respira-
tory morbidity and mortality [1–3]. This link has proven
strongest for fine combustion-derived PM (particle diam-
eter < 2.5 μm; PM2.5) [4]. Exhaust from diesel engines is an
important contributor to PM2.5 in urban environments, as
well as being a major source of smaller combustion-derived
nanoparticles [5]. Time in traffic has been associated with
triggering of acute myocardial infarction [6] and there is a
wealth of data from controlled human experimental expos-
ure studies showing that petrodiesel exhaust (PDE) has
multiple adverse effects throughout the cardiovascular
system [7–10].
Due to adverse environmental effects of fossil fuels,
considerable efforts have been made to find alternative
renewable energy sources. The European Union has a
current target for 10% use of biofuels within transporta-
tion (EU Directive 2009/28/EC), Finland targets 30%
biofuel by 2030 [11] and similar efforts are planned in
the US, China, India and elsewhere [12].
The ideal biofuel would be cheap to produce, compat-
ible with existing infrastructure and engine technologies,
but, importantly, would not cause harm to either human
health or the environment [13]. Biodiesel (diesel fuel made
from biological substances rather than petroleum sources)
meets several of these criteria and, as a result, it is increas-
ingly added to petrodiesel used in commercial and indus-
trial settings [14, 15].
Untreated oils from vegetables and plants are not suit-
able to run in modern diesel engines without a trans-
esterification process. When rapeseed oil is used, the
end product is rapeseed methyl ester (RME), which has
good ignition and lubrication properties. RME is popular
in Europe as it can be produced locally, blended into
petrodiesel and used in existing diesel engines. Novel
production methods of biodiesel are being developed to
decrease land usage and increase yield, however, cur-
rently rapeseed and soybean are the major crops for bio-
diesel production in Europe and the US, respectively.
While the efficiency of biofuel combustion has been well-
studied, relatively little focus has been directed towards the
health effects of emissions generated from biofuels, despite
the rapid introduction of these fuels in societies and calls
for such research [14, 16]. Several in vitro studies and ani-
mal studies have addressed the potential health effects of
biodiesel exhaust exposure [17–19], but, to our knowledge,
there is only one human exposure study in a mining envir-
onment reporting on respiratory and peripheral blood in-
flammatory markers [20].
In the present study, we assessed the potential acute
vascular and thrombotic effects of replacing petrodiesel
with a 30% or 100% rapeseed biodiesel formulation, fol-
lowing controlled exposure in young healthy volunteers.
It was hypothesized that inhalation of exhaust from bio-
diesel formulations would induce lesser cardiovascular
effects compared to standard petrodiesel fuel.
Results
Sixteen subjects completed study one (RME30 vs. PDE
exposure and 19 subjects completed study two (RME100
vs. PDE exposure) (Table 1). The studies were well toler-
ated by all subjects with no adverse events. There were
no significant differences in lung function measured as
VC and FEV1 pre vs. post exposure (data not shown).
Exposures
In study one (RME30 vs. PDE), the comparison aimed at
a target concentration in the exposure chamber of PM2.5
300 μg/m3 for both fuel types. To account for the
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commonly observed lower PM mass emissions of bio-
diesel, study 2 (RME100 vs. PDE) was not designed for
equal PM mass concentrations in the exposure chamber.
Rather, the RME100 exposure was using similar engine
and exhaust dilution settings as the PDE exposure
(aimed at PM10 300 μg/m
3), which resulted in lower
mass emissions of RME100 PM.
Basic characterization of RME30 exhaust was relatively
similar to that of PDE, as regards PM10, total hydrocar-
bons and elemental carbon/organic carbon ratio (EC/OC
ratio) (Table 2). Compared to PDE, RME100 exhaust con-
tained more and smaller particles. (Table 2, Fig. 1).
RME100 exhaust particles had a lower EC/OC ratio and
less particle-bound polycyclic aromatic hydrocarbons
(PAHs), as compared with PDE. The gas phase of RME30
and RME100 exhaust contained higher concentrations of
NOx than PDE. The fact that NOx differed slightly be-
tween RME exposures, was due to minor tuning issues re-
quired by the engineers managing the exposure set up.
The oxidative potential (OP) of PM measured with elec-
tron paramagnetic resonance (EPR) showed a lower oxida-
tive potential with increasing RME content within the fuel.
The RME100 fuel sample generated significantly less super-
oxide free radicals per mass of PM than the petrodiesel or
RME30 (Fig. 2). Oxidative potential (OP) was also mea-
sured by the quantification of antioxidant losses from a syn-
thetic respiratory tract lining fluid. This generated two
metrics, based on ascorbate and glutathione oxidative con-
sumption over a 4-h incubation period, OPAA and OPGSH
respectively, expressed per unit mass (μg) of extracted PM.
These data are illustrated in Fig. 2, panel a, for each fuel
type and for the individual < 0.2 and 0.2–0.5 μm fractions.
To allow comparison with the EPR data, the OPAA and
OPGSH values have been aggregated to provide a total oxi-
dative potential (OPTOT) across both fractions, which was
equivalent to the sample employed for the EPR analysis.
This composite measure of oxidative potential showed a
similar overall pattern to that observed by EPR, with de-
creasing activity as the proportion of RME increased. The
individual ascorbate and glutathione dependent OPs pro-
vided a less coherent pattern, with RME 100 having the
lowest OPAA and RME30 the lowest OPGSH activities.
Of the metals considered, there were significantly
higher levels of manganese (Mn), iron (Fe), vanadium
(V), nickel (Ni), chromium (Cr) and molybdenum (Mo)
in the RME30 blend and pure RME100, relative to the
PDE in both the PM< 0.2 μm and PM0.2–0.5 μm size
ranges (Fig. 2, panel b). The concentrations of the
remaining metals/metalloids measured in each fuel frac-
tion are summarised in Supplementary Table S1.
Vascular and thrombosis studies
Plethysmographic data and net t-PA release were deter-
mined as described previously [21, 22]. Infusion of all
Table 1 Subject characteristics
Parameter Study one, n = 16, 2 females. Study two, n = 19, all males
Age, years 25 (21–29) 28 (20–38)
Height, cm Males: 181 (173–195)
Females: 171 (166–176.5)
181 (168–190)
Weight, kg Males: 75 (67–88)
Females: 69 (60–79)
79 (55–97)
BMI, kg/m2 Males: 23 (20–25)
Females: 23 (21–25)
24 (19–29)
Pre exposure measures Petrodiesel RME30 Petrodiesel RME100
Vital capacity, L 5.8 ± 0.3 5.9 ± 0.3 6.3 ± 0.3 6.3 ± 0.3
FEV1, L 4.6 ± 0.2 4.6 ± 0.2 4.8 ± 0.2 4.8 ± 0.2
FENO 50, ppb 12 ± 1 11 ± 1 13 ± 1 15 ± 2
Systolic blood pressure, mm hg 121 ± 3 123 ± 2 136 ± 3 135 ± 3
Diastolic blood pressure, mm hg 69 ± 1 71 ± 1 79 ± 2 78 ± 2
Heart rate, bpm 65 ± 2 64 ± 2 68 ± 2 67 ± 2
Hemoglobin, g/L 148 ± 3 147 ± 3 151 ± 2 151 ± 2
Leukocyte particle concentration × 109/L 5.7 ± 0.3 5.7 ± 0.4 5.4 ± 0.2 5.5 ± 0.3
Platelet concentration, ×109/L 231 ± 11 236 ± 11 232 ± 11 230 ± 10
Lymphocytes, ×109/L 2.1 ± 0.2 2.1 ± 0.2 2.2 ± 0.2 2.2 ± 0.2
Monocytes, ×109/L 0.5 ± 0.0 0.5 ± 0.0 0.5 ± 0.0 0.5 ± 0.0
Neutrophils, ×109/L 2.9 ± 0.2 3.0 ± 0.2 2.6 ± 0.1 2.6 ± 0.2
Median and range for anthropomorphic measures. Mean ± standard error of the mean (SEM) for pre-exposure baseline cardiorespiratory and
hematological measures
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vasodilators generated a dose-dependent increase in
forearm blood flow (2-way ANOVA for incremental
doses of acetylcholine, bradykinin, sodium nitroprusside
and verapamil, p < 0.05 for all drugs following all expo-
sures). The vasodilatation was similar in both studies
comparing responses for the respective agonists follow-
ing PDE vs. RME30 (Study 1; n = 15) and PDE vs.
RME100 (Study 2; n = 18) (2-way ANOVA comparing
each drug in incremental doses following respective ex-
posure; p > 0.05 for all, Fig. 3. A filtered air arm could
not be included in the present study, due to the exten-
sive logistical aspects of mounting three-arms studies
with bilateral arm canulations and infusions. However,
the consistent and very repeatable attenuation of vaso-
dilatation by PDE vs. filtered air, based on pooled
historical data from four studies [23–26] is given in Fig.
S1 in the supplement.
In both studies, ex vivo thrombus formation was simi-
lar following all exposures with mean total thrombus
area in the perfusion chamber being 10,192 (95% CI
[7718, 12,665]) μm2 following PDE and 10,888 (95% CI
[8815, 12,922]) μm2 following RME30 exhaust in study
one (n = 13), and 8973 (95% CI [8175, 9771]) μm2 fol-
lowing PDE and 9424 (95% CI [8194, 10,654]) μm2 fol-
lowing RME100 exhaust in study two (n = 19) (p = 0.37
and 0.48, respectively, Fig. 4).
In both studies, mean plasma t-PA antigen concentra-
tions were similar after all exposures, with 4.9 (95% CI
[3.7, 6.1]) ng/mL following PDE and 4.7 (95% CI [3.4,
5.9]) ng/mL following RME30 exhaust in study one (n =
14), and 5.2 (95% CI [4.0, 6.4]) ng/mL following PDE
and 6.3 (95% CI [4.5, 8.2]) ng/mL following RME100 ex-
haust in study two (n = 17) (Fig. 5, left panel). Bradykinin
infusion caused a dose dependent release of t-PA that
was similar following all exposures to PDE and RME,
with no significant differences between the paired expos-
ure scenarios (p = 0.43 for PDE vs. RME30 and p = 0.35
for PDE vs. RME100; 2-way ANOVA) (Fig. 5, right
panel).
Blood cell counts and platelet activation
There was a similar (p > 0.05 for all) transient rise in
neutrophils following all exposures, that had returned to
baseline by 24 h post exposure (Supplement Table S2).
However, there were no differences between exposures.
Mean platelet activation did not differ between expo-
sures, with mean platelet CD40 ligand and P-selectin ex-
pression and platelet-monocyte binding all being similar
at 2 and 4 h post exposure, (p > 0.05 for all, Supplement
Table S3).
Fig. 1 Particle size distribution during PDE and RME100 exhaust
exposure. Mean with standard deviation. Exposures were kept
constant and measurements (n = 3) were spread out over the
exposure series
Table 2 Exposure characteristics
Study one Study two
Petrodiesel RME30 Petrodiesel RME100
PM10, μg/m
3 314 ± 27 309 ± 30 310 ± 34 165 ± 16
Total Hydrocarbons, ppm 1.0 ± 0.1 0.9 ± 0.1 0.9 ± 0.2 0.9 ± 0.2
NOx, ppm 3.9 ± 1.0 4.6 ± 1.0 6.1 ± 0.4 7.3 ± 0.5
NO2, ppm 0.7 ± 0.1 0.3 ± 0.1 0.4 ± 0.1 0.5 ± 0.1
Temp, C 22 ± 1 22 ± 1 22 ± 2 22 ± 1
Relative humidity, % 36 ± 13 33 ± 11 28 ± 11 30 ± 13
Particle number concentration ×105/cm3 n/a n/a 1.7 ± 3.2 2.2 ± 1.4
EC/OC, ratio* 0.66 ± 0.01 0.64 ± 0.02 n/d 0.43 ± 0.03
Particle bound PAHs, ng/m3 156 ± 16 127 ± 15 n/d 76 ± 24
Semi volatile PAHs, ng/m3 244 ± 81 158 ± 37 n/d 225 ± 167
Exposure characteristics, mean and standard deviation. *Elemental (EC) and organic (OC) carbon. Semi-volatile PAHs are the sum of; phenanthrene, anthracene, 3-
methylphenanthrene, 2-methylphenanthrene, 2-methylanthracene, 9-methylphenanthrene, 1-methylphenanthrene, 4H-cyclopenta [def] phenanthrene, 2-
phenylnaphthalene, 3,6-dimethylphenanthrene, 3,9-dimethylphenanthrene, fluoranthene, pyrene, 2-methylpyrene, 4-methylpyrene, 1-methylpyrene, benz [a]
anthracene, and chrysene. For Study one n = 16 and for study two n = 19, except EC/OC and PAHs n = 3 for studies one and two
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Fraction of exhaled NO
There were no significant changes in FENO50 following
exposures or differences comparing respective exposures
(Supplement Table S4).
Discussion
To our knowledge, this study represents the first detailed
investigation of the impact of biodiesel exhaust emis-
sions on functional cardiovascular endpoints (vasomo-
tion, thrombus formation, fibrinolytic markers, platelet
function and blood cell differential including inflamma-
tory cells) in healthy human volunteers. The study also
performed a detailed characterization of the tail-pipe
emissions, with physiochemical profiling of the PM
within the exhaust. We have shown that, despite chem-
ical and physical differences, the acute effects of bio-
diesel exhaust inhalation on thrombus formation and
the vascular system were similar to those observed upon
PDE exposure.
Numerous controlled experimental exposures studies
in human volunteers have shown that exposure to PDE
causes acute cardiovascular and respiratory effects.
Acute exposure has consistently been shown to induce
endothelial dysfunction, in terms of impaired vasomotor
function and endogenous fibrinolysis [7, 8, 23–25, 27].
Inhalation of PDE also induces thrombus formation [8,
23, 26] platelet activation [7, 8, 23], arterial stiffness [9]
as well as systemic and airway inflammation [20, 28–31].
Exposure to fine PM of concentrated ambient urban
particles (CAPs) has also been found to increase blood
pressure and arterial vasoconstriction [32].
The vascular effects of PDE compared with filtered air
exposures have been highly consistent in previous stud-
ies from our group. Specifically, when compared with fil-
tered air exposures, PDE exposures have resulted in
Fig. 2 Oxidative potential and metal content of exhaust PM derived from petrol diesel and RME blended fuel combustion. Panel a shows
superoxide free radical generation using electron paramagnetic resonance (EPR) with the spin-trap Tempone-H (1 mM). All particulates were
suspended at an equivalent concentration of 0.1 mg/mL in physiological saline. Pyrogallol (0.1 mM) is used as a positive control to spontaneously
generate superoxide. RME100 generated significantly less superoxide than petrodiesel (*p < 0.05) or RME30 (†p < 0.05) (unpaired t-tests, n = 6–10).
Panel b represents ascorbate- and glutathione-dependent oxidative potentials (OPAA and OPGSH, respectively) for the PM < 0.2 μm and PM0.2–
0.5 μm fractions are illustrated, with the data expressed per μg of extracted PM (n = 3, separate filters, per fraction and fuel type). A total
aggregated OP (OPTOT) is also illustrated reflecting the sum of the OPAA and OPGSH measures. Data are illustrated as means with standard
deviation, with comparison between groups performed on the sum of the OP for the two fractions combined using the students t-test (P < 0.05):
‘a’ petrol diesel vs, RME30; ‘b’ RME30 vs RME100; no significant differences were observed between petrol diesel and RME100. Panel c represents
the concentration of a selection of the measured metals in both PM fractions derived from each fuel type (n = 3). Zn = zinc, Cr = Chromium, V =
Vanadium, Mn =Manganese, Cu = Copper, Mo =Molybdenum, Ni = Nickel, Fe = Iron. Asterisks represent significant differences (p < 0.05) in
concentration relative to petrodiesel. No significant differences were noted between the fuel types in the PM < 0.2 μm fraction and metal
concentrations did not differ between the two fractions under each condition
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impairment of vasomotor function along with increased
blood thrombogenicity and platelet activation [7, 8, 23–
27]. In Fig. S1 we display the clear and consistent vaso-
motor dysfunction caused by exposure to PDE vs. fil-
tered air based on pooled data from four historical
studies using similar set ups [23–26]. Performing experi-
mental studies with a three arm design with exposures,
canulations and infusions is logistically and practically
very difficult to perform, according to our experiences
[26]. We therefore decided not to replicate the well-
established vasomotor effects of PDE exhaust vs. filtered
air (Fig. S1), but prioritized a direct comparison of the
effects of PDE exhaust with RME biodiesel exhaust, in
subjects exposed in the same facility and assessed by
Fig. 3 Forearm blood flow during intrabrachial infusion of vasoactive drugs 4–6 h post exposure, mL/100mL tissue. Mean with 95% CI. The graph
shows response to incremental doses of acetylcholine, bradykinin, sodium nitroprusside and verapamil following respective exposure. All
vasodilators caused an increase in blood flow (p < 0.05 for all) that was similar between exhaust exposures (p > 0.05 for all). P values in the graph
for respective vasodilator response in the infused arm following exposure to RME30 exhaust compared to PDE (n = 15) and RME100 exhaust
compared to PDE (n = 18), 2-way ANOVA
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similar methods as previously. In contrast to vascular
and thrombotic measures, our previous studies
showed only modest and variable effects on second-
ary endpoints such as systemic inflammatory re-
sponses in terms of blood cells, soluble markers of
inflammation and exhaled NO. By using an identical
exposure setup and study design as in our previous
experimental exposure studies, we have, for the first
time, been able to show that replacing petrodiesel
with RME30, or RME100, does not substantially alter
the vascular response compared to exposure to con-
ventional PDE exhaust. Cardiovascular outcomes
(blood flow responses and thrombus formation) were
similar for PDE and RME30 under exposure condi-
tions that generated similar particle mass concentra-
tions and, for PDE and RME100, when emission
factors were held constant. Thus, these findings
imply that the emissions from the RME employed
would have comparable adverse effects on cardiovas-
cular health as conventional PDE.
Biodiesel differs from petrodiesel in chemical compos-
ition, as it consists mainly of fatty acid methyl esters,
whereas petrodiesel mainly contains saturated aliphatic
hydrocarbons and aromatics. This gives biodiesel a
higher cetane number, meaning it ignites faster [33]. It
has also an increased ratio of oxygen, which lowers
Fig. 4 Ex vivo thrombosis formation in a model of acute arterial injury. Individual data points for mean thrombus area for each individual, line for
group mean with 95% CI. There were no significant differences between RME30 and PDE (study one) or RME100 and PDE (study two) RME30 vs.
PDE p = 0.37, n = 13 and RME100 vs. PDE p = 0.48, n = 19. P values from paired Student’s t-test
Fig. 5 Mean plasma t-PA antigen concentrations after exposure to petrodiesel vs. RME 30 (upper left panel) and petrodiesel vs. RME100 (lower
left panel) were not significantly different between exposures (p = 0.73 and p = 0.22, respectively). Stimulated release of t-PA plasma antigen
concentrations following incremental doses of bradykinin infusions, expressed as nanogram per 100 mL tissue per minute, mean with 95% CI
(upper and lower right panels). Bradykinin infusions caused dose dependent increases in t-PA antigen concentrations that were significant at p <
0.01 level for all exposures; petrodiesel and RME 30 (upper right panel) as well as petrodiesel and RME 100 (lower right panel) by 2-way ANOVA.
The bradykinin stimulated increases in t-PA did not differ between petrodiesel or RME exposures (p = 0.43 and p = 0.35, respectively).
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energy density and, at the same time, increases oxygen
content in the ignited fuel spray. Increased oxygen con-
tent (which reduces soot formation) together with lower
content of aromatics (soot precursors) and sulfur act to-
gether to decrease particulate emissions from biodiesel
compared to petrodiesel [33]. Consistent with our find-
ings, previous studies have demonstrated that increased
biodiesel content in blends with petrodiesel fuel, is asso-
ciated with reduced PM mass and increased NOx [20,
34, 35]. In addition, previous studies have indicated that
addition of biodiesel to conventional petrodiesel fuel is
associated with reduced CO emissions and a higher
organic fraction and, in contrast to the present study,
reduced hydrocarbons [36]. In RME30, exhaust con-
centrations of PM-bound PAHs were considerably
lower compared to petrodiesel, in line with previous
studies [37].
We suggest that it is unlikely that the minor differences
in gaseous components, such as NOx, would play a signifi-
cant role eliciting the acute cardiovascular effects, as pre-
vious exposure studies of the gaseous components alone,
or of pure NO2 at similar concentrations, did not result in
any acute cardiovascular impairment [26, 27, 38].
In the present study, the substitution of petrodiesel
with a 100% RME formulation.
reduced the PM mass concentration when emission
factors were held constant, but slightly increased the
particle number concentration, along with a shift in the
size distribution towards the ultrafine range (< 100 nm).
We demonstrated a shift from a mono-modal distribu-
tion with a peak around 100–140 nm for the PDE expo-
sures to a bi-modal distribution with one peak around
80–90 nm and a second larger peak around 30–40 nm
during the RME100 exposures. In previous studies, there
has been some inconsistency when it comes to size dis-
tribution of PM in biodiesel exhaust compared to PDE.
Several reports support a similar shift towards smaller
particles and an increase in total particle number in
RME exhaust [34, 39–41], whereas others have found
decreased particle number concentrations [42]. It has
been suggested that the ultrafine (< 100 nm) mode of
RME exhaust may be composed either of organic matter
from RME fuel residues or production constituents with
high boiling points, such as triglycerides and glycerol, or
of inorganic fuel constituents and/or impurities such as
alkali metals, metalloids and trace metals, which may act
as condensation nuclei for condensable organics [41].
From our results, it is not possible to draw any conclu-
sions regarding the composition of the different particle
size modes. Though, still the subject of debate, it has
been proposed that PM in the ultrafine range may be a
major contributor to the adverse health effects following
inhalation, due to greater surface area relative to mass of
PM and higher deposition in the alveoli [43, 44]. In
relation to health effects, particle size remains a complex
issue, which is yet to be resolved and it remains specula-
tive to suggest to what extent the shift in particle size in-
fluenced any endpoints in the current studies.
In our study, we found the oxidative potential of PM
from RME exhaust to be lower than that of PM from
PDE. Others have suggested RME-derived PM to have
similar, or less, oxidative potential than petrodiesel ex-
haust [45], whilst soy-derived biodiesel PM may have in-
creased oxidative potential (measured as dithiothreitol
consumption) compared to petrodiesel-derived PM on a
per mass basis [46]. This inconsistency may reflect that
biodiesel exhaust in general, and particle properties in
particular, is highly variable due to different fuel sources,
formulations, storage conditions and combustion prop-
erties and engine conditions [13, 47, 48].
Oxidative stress is thought to be a key underlying
mechanism driving inflammation following PM exposure
[3, 44, 49]. We demonstrated a mild transient systemic
inflammation, in terms of increased neutrophil counts,
that was similar following all exposures over the obser-
vation period. In a study investigating the relative tox-
icity of PM from different fuels on mouse macrophages,
Jalava et al. reported dose-dependent inflammation re-
sponses that were similar, or slightly smaller, for RME
compared to petrodiesel-derived PM. This trend was
stronger with catalytic after-treatment of the exhaust, or
when the emission factor was taken into account, as
RME produced less PM [45]. Oxidative stress can also
result in DNA damage and, in previous in vitro studies,
RME-derived PM has been shown to increase mutage-
nicity and cytotoxicity [42, 48, 50] compared to PDE.
Complementary techniques, such as omics approaches,
have potential to elucidate mechanism further, but were
not included in this study [51]. Cell based techniques
may also further delineate the complexity of the oxida-
tive processes.
In this study, we aimed to assess the cardiovascular ef-
fects of biodiesel/biodiesel blend, as an alternative fuel
to petrodiesel. Given the aim and that the findings of
diesel exhaust-induced endothelial dysfunction, in terms
of blunted vasomotor function and impaired endogenous
fibrinolysis, together with increased ex vivo thrombus
formation, are highly reproducible and consistent in a
long series of studies [7–9, 23–27], we did not include a
filtered air exposure. The addition of an air exposure
would also have added substantially to the complexity of
the study, demanding exposures and invasive vascular
investigations, three times in each participant. While
there at present is no directly comparable controlled ex-
posure study in human subjects investigating detailed
biodiesel-induced cardiovascular endpoints, the study by
Mehus and coworkers provides some opportunities for
comparisons [52]. That study was performed in a mining
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environment and compared health endpoints in human
subjects from a pre-exposure day with measurements
carried out in the aftermath of two separate exposures
to PDE and to a biodiesel blend (75% soybean methyl
ester (SME) with 25% PDE). The data indicated slightly
reduced lung function, increased inflammatory markers
in peripheral blood and induced sputum, which did not
differ between the petrodiesel and SME 75% biodiesel
exhaust exposures [20]. No filtered air exposure day was
included, reflecting the complexity of performing expos-
ure studies of health effects in human volunteers.
Limitations of the study
The study was not gender balanced, which means the
findings cannot be inferred to be applicable in females
as well. Our series of earlier studies has, however, not
indicated any sex related differences in the vascular
response to diesel exhaust.
It is also recognized that subjects with pre-existing dis-
ease such as cardiovascular or respiratory diseases have
not been studied and could potentially be a more sensi-
tive and reactive population. The subjects were only
studied after one single exposure, whereas in real life re-
peat exposures could potentially elicit enhanced re-
sponses. Respiratory effects were addressed to a limited
extent in this study and should be explored in more de-
tail in further studies. These aspects all warrant further
research into health effects of exhaust from renewable
engine fuels in different settings and groups.
Conclusion
In healthy subjects, exhausts from the two biodiesel for-
mulations RME30 and RME100 were not shown to have
significantly different effects on any investigated marker
of vascular function or thrombus formation compared to
PDE, despite contrasting physico-chemical properties.
We suggest that replacing petrodiesel with RME30 or
RME100 does not alleviate acute cardiovascular impair-
ment following exhaust inhalation, even in light of re-
duced PM mass. Whilst there are potential environmental
benefits of introducing biofuels, the effects on human
health should be a strong consideration when the future
use of alternative fuels are determined.
Methods
The study assessed the acute vascular and thrombotic ef-
fects of replacing petrodiesel with a 30% or 100% rapeseed
biodiesel formulation, following controlled exposure in
healthy human subjects. It was hypothesized that inhal-
ation of exhaust from biodiesel formulations would induce
less vascular effects compared to standard petrodiesel fuel.
Study design
Two separate randomized controlled double-blind cross-
over studies were conducted. In study one, 16 subjects
(14 male) were exposed both to PDE and exhaust gener-
ated from a biodiesel blend of 30% RME and 70% petro-
diesel (RME30) on separate occasions. For females, the
exposures were carried out in the same phase of the
menstrual cycle. In study two, 19 subjects (all male) were
separately exposed both to exhaust from 100% RME bio-
diesel without blending with petrodiesel (RME100) and
PDE. In both studies, exposures were allocated in ran-
dom order at least one week apart. Exposures were
blinded for the subjects and researchers involved, but
known to the engineer running the exposure facility
from an adjacent room. Investigators were unblinded to
the exposure codes only after completion of the full stat-
istical analyses.
Exposures lasted one hour with intermittent exercise
on a bicycle ergometer for 15 min alternating with 15
min rest. The bicycle ergometer was calibrated to give a
minute ventilation during exercise of 20 L/m2 body sur-
face area, as determined during a pre-test day. Exposures
were conducted at the same time in the mornings in a
purpose-built human exposure chamber, as described
previously [23]. Study 1 was performed April–June with
an interval of 7–50 days (mean 20 days) between expo-
sures and study 2 September–December with a 7–46-
day interval (mean 39 days). Subjects were not allowed
to take any medication, supplemental vitamins or antiox-
idants during the week before and during the study and
instructed to take a light low nitrate breakfast on expos-
ure days, but otherwise to maintain their normal diet. At
mid-day, subjects were given a standardized snack con-
sisting of a protein drink and a piece of fruit. No other
food or drink other than water was allowed during the
measurements.
Study population
Thirty-six healthy subjects (34 men and 2 women, aged
20–38 years, mean 27 years) were recruited, according to
Good Clinical Practice (GCP) principles and as approved
by the regional ethical review board and the study was
performed in accordance with the Declaration of
Helsinki, with the written informed consent from all
participants. All volunteers were never regular smokers.
A history of limited occasional social smoking was
allowed, but not within the last 6 months. They under-
went a physician interview and physical examinations
and were determined to have normal physiologic param-
eters, body mass index (BMI), lung function, blood
chemistry and electrocardiogram, according to the nor-
mal values of the hospital. Exclusion criteria were dia-
betes mellitus, cardiovascular disease, asthma, smoking
or snus usage (powdered tobacco used orally). Female
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subjects took a urinary pregnancy test before each ex-
posure to exclude pregnancy and subjects currently
using birth control were excluded. The subjects were all
healthy without any current disease or prescribed medi-
cation, including non-steroidal anti-inflammatory drugs
(NSAID). All were instructed to maintain their normal
diet, with no major changes, or additional intake of anti-
oxidant rich components. The imbalance of sex in the
study was unintentional and depending on responses to
participate in the study: As a consequence, study data
are mainly related to male gender.
Exhaust exposure
RME100 biodiesel and low-sulfur standard diesel (petro-
diesel) were acquired from Preem AB (Stockholm,
Sweden). RME30 was blended on site using RME100
and petrodiesel. The RME30 contained the proprietary
fuel additive ACP (Active Cleaning Power) according to
instructions from the fuel company. The additive has
been indicated to improve combustion and decrease en-
gine deposits and is intended to be commercially avail-
able. The exact chemical composition is confidential,
however, Preem AB has disclosed it to consist of deter-
gent, lubricant and cetane-number improving agents,
given as personal information to a lead engineer at the
SMP engineering site running the engine set up.
Exhaust was generated using a Volvo diesel engine
(Volvo TD40 GJE, 4.0 L, 4 cylinders) running under vari-
able load, according to the urban part of the European
Transient Cycle [25]. This engine represents an older
generation of diesel engines, that are still widely used, as
these engines are extremely durable with slow turnover
time from a global perspective. More than 90% of the
exhaust was shunted away and the remainder was mixed
with filtered air and fed into the exposure chamber to
generate a target PM10 (PM with a mean aerodynamic
diameter of < 10 μm) concentration of 300 μg/m3 for
both PDE and RME30 [28]. For the RME100 exposure,
an identical driving cycle was used with the same load
and rounds per minute (rpm) pattern, without modifica-
tions to the engine, exhaust dilution system or exposure
chamber. The study was specifically designed to investi-
gate the health effects of the exhaust from a specific ve-
hicle when replacing PDE with RME under the same
driving conditions rather than similar PM mass concen-
tration in the chamber for the exposures.
Emission characterization
PM10 concentration was determined gravimetrically
using PTFE filters (Pall Teflo Life Science 47mm, 2 μm).
Real-time measurement of PM10 with a tapered-element
oscillating microbalance (Rupprecht & Patashnik, Al-
bany, New York, USA) was used during exposures to
achieve steady PM levels at 300 μg/m3 [25]. A scanning
mobility particle sizer system (SMPS TSI, Shoreview,
Minnesota, USA) was used to determine fine particle
number concentration and size distribution (18–638
nm), which included an electrostatic classifier platform
(TSI 3080, TSI GmbH) with a Differential Mobility
Analyzer (TSI DMA 3081) and an ultrafine Condensa-
tion Particle Counter (TSI CPC 3025A). In addition, PM
was also sampled by a Dekati Gravimetric Impactor
(DGI) for subsequent analysis of metals and oxidative
potential. The DGI classifies particle size according to
aerodynamic diameter (cut-points; 2.5, 1.0, 0.5 and
0.2 μm). 47 mm PTFE plates were used as impactor sub-
strates and 70mm PTFE filters as back-up filters (<
0.2 μm). Exposure concentrations were kept as constant
as possible and samples were collected at intervals to re-
flect the average exposure scenarios.
For the carbon fractionation, standard 47 mm tissue
quartz filters and 47mm PTFE membrane filters were
used. The analysis of particulate carbon fractions was
performed by a standard thermal-optical method to de-
termine the content of organic carbon (OC) and elemen-
tal carbon (EC) applying the EUSAAR 2 thermal
protocol and a thermal-optical carbon analyzer (Sunset
Laboratory Inc., Portland, Oregon, USA).
Assessment of metal content in exhaust particulate
Metal content was assessed using an ELAN DRC ICP-
MS (MSF008). The three last stages of the DGI sampler
were used, i.e. filters; PM< 0.2, PM0.2–0.5 and PM0.5-1μm
and the extraction was performed in HPLC-grade
methanol, followed by vortexing and sonication in a
water bath (max power, Clifton SW12h, Nickel-Electro
Ltd., Weston-super-Mare, UK). The removed filter was
then rinsed in methanol. Particle extract was subse-
quently dried down under nitrogen and recovered mass
determined. Mass recoveries for the PM< 0.2 and PM0.2–
0.5 μm filters were good; 84.0 ± 21.3% (filter loadings ran-
ging from 510 to 860 μg) and 113.0 ± 38.7% (170–
370 μg) respectively. Recoveries from the PM0.5–1.0 μm
filters were poor, reflecting the low filter loadings (20–
180 μg) and were not used for subsequent analysis. Fol-
lowing particle resuspension in 1.0 mL of Chelex resin-
treated water (sonication at max power), 100 μL aliquots
were added to dilute Aqua Regia, spiked with an internal
standard containing 1 ppm indium (isotope 115), gallium
(69), bismuth (209) and yttrium (89), sealed in Teflon
vessels and placed in a 90 °C water bath. The mixture
was cooled prior to the addition of Chelex-resin treated
water. Metals quantified were: aluminum [26], arsenic
(75), barium (135), beryllium [9], manganese [53], van-
adium [51], antimony (121), cadmium (111), chromium
[54], copper (63), molybdenum (95), nickel (60), lead
(208), zinc (66), strontium (88), calcium [45], iron (56),
boron [11], cobalt (59), rubidium (85), cesium (133),
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gold (197). Elemental concentrations were determined
with reference to a 6-point standard curve based on an
ICP multi element standard solution VI CertiPUR®
(Merck, Lot. No. OC529648) or, where not present, in
the multi-elemental standard the elements own standard
curve (ICP standard, MERCK).
Measurement of PAHs in exhaust
For collection of particulate and semi-volatile PAHs,
sampling with 47mm glass fiber filters followed by 70
mm polyurethane foam plugs (PUFs) were performed in
the chamber during the exposures. Both filters and poly-
urethane foam plugs (PUFs) were spiked with an isotope
labeled internal standard mixture. The samples were
extracted with pressurized liquid extraction using an
ASE 200 Accelerated Solvent Extractor system (Dionex
Corporation, Sunnyvale, CA, USA). PUFs were extracted
using hexane at 100 °C and 1100 psi (7.58MPa). Particles
were extracted with toluene/methanol 9:1 (v/v) at 200 °C
and 3000 psi (20.7MPa).
The raw extracts were concentrated to approximately
0.5 mL followed by solid phase extraction (SPE), and the
SPE-purified extracts were analyzed using an in-house
built HPLC-GC-MS system [54]. Data were acquired and
processed using MSD ChemStation (Agilent Technolo-
gies, Santa Clara, California, USA). PAHs were quantified
using single point calibration. Compound identity was de-
termined through compound specific mass to change ratio
and its relative retention time on the GC capillary column.
Reported concentrations of semi-volatile PAHs are the
sum of; phenanthrene, anthracene, 3-methylphenanthrene,
2-methylphenanthrene, 2-methylanthracene, 9-methylphen-
anthrene, 1-methylphenanthrene, 4H-cyclopenta [def] phen-
anthrene, 2-phenylnaphthalene, 3,6-dimethylphenanthrene,
3,9-dimethylphenanthrene, fluoranthene, pyrene, 2-
methylpyrene, 4-methylpyrene, 1-methylpyrene, benz [a]
anthracene, and chrysene. Reported concentrations of PM
associated PAHs include those measured in the semi-
volatile phase and the sum of benzo [b] fluoranthene, benzo
[k] fluoranthene, benzo [e] pyrene, benzo [a] pyrene, pery-
lene, indeno [1,2,3-cd] pyrene, and benzo [ghi]perylene.
Assessing oxidative potential of PM
Oxidative potential of PM was first determined by electron
paramagnetic resonance (EPR; or electron spin resonance)
by measuring oxidation of a spin-trap with preferential se-
lectivity for superoxide free radicals [55]. Briefly, 47mm tef-
lon filters with PM were suspended in a physiological saline
solution (Krebs buffer) at a particle concentration of
100 μg/mL Samples were vortexed, followed by sonication
(100% power; Fisherbrand FB11002; Fisher Scientific,
Loughborough, UK). Suspensions were incubated with the
spin-trap, Tempone-H (1mM; Enzo Life Sciences, Exeter,
UK), for 60min before measurement. Pyrogallol (100 μM),
a spontaneous generator or superoxide radicals, was
used as a positive control. An X-band EPR spectrom-
eter (Magnettech MS-200, Berlin, Germany) was used.
Baseline signals from blank filters were subtracted
from that of filters with particulate.
Oxidative potential of PM was also determined by
measuring glutathione levels in a synthetic respiratory
tract lining fluid (sRTLF) following in vitro exposure to
PM. Extracted PM (50 μg/mL) was incubated in sRTLF
containing physiologically relevant concentrations of
urate (UA), ascorbate (AA) and glutathione (GSH), ad-
justed to pH 7.0 and incubated at 37 °C for four hours.
Samples were centrifuged to remove particles, prior to
samples acidification with metaphosphoric acid (final
concentration 5% w/v). The remaining concentrations of
ascorbate and urate were quantified using reverse phase
HPLC with electrochemical detection (Jones Chroma-
tography, Hengoed, Wales). Glutathione concentrations
were determined with the GSSG-reductase-5,5′-dithio-
bis(2-nitrobenzoic acid) (DNTB) recycling assay. Full de-
tails of the methodology and derivation of the OP met-
rics have been described previously [53, 56].
Ex vivo blood coagulability model
Ex vivo thrombus formation was assessed two hours
post-exposure using a Badimon chamber perfusion
model of acute arterial injury as described previously [8].
In brief, a venous cannula is inserted into an antecubital
vein and blood drawn using a peristaltic pump at a rate
of 10 mL/s via tubing connected to a perfusion chamber
submerged in a water bath at 37 °C. This model of acute
arterial injury consists of three consecutive chambers
containing porcine aortic strips from which the intima is
removed, to exposure a prothrombotic surface that sim-
ulates deep arterial injury following plaque rupture.
Blood is passed through the chambers for five minutes,
followed by rinsing with saline. The strips are removed,
fixed in paraformaldehyde, embedded for histological
analysis, then cut and stained with Masson’s trichrome.
The sections are analyzed using a semi-automatic micro-
scope and total thrombus area quantified [8].
Vascular endothelial function
Vascular vasomotor function was assessed using forearm
venous occlusion plethysmography four to six hours
after each exposure, as described previously [23–25, 27].
The brachial artery was cannulated with a 27-standard-
wire-gauge steel needle. Following a saline infusion, four
vasodilator drugs, reflecting NO-dependent and non-
NO-dependent (verapamil) vasodilation, were infused
separately at 1 mL/min in incremental doses separated
by washouts to restore baseline flow. Bradykinin (100,
300 and 1000 pmol/min); acetylcholine (5, 10 and 20 μg/
min); sodium nitroprusside (2, 4 and 8 μg/min) were
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infused in random order, and verapamil (10, 30 and
100 μg/min) was infused last due to its long acting ef-
fects. Mercury-in-silicone strain gauges were used to as-
sess forearm blood flow in both arms (infused arm and
non-infused arm) simultaneously. Bradykinin induces
the release of the fibrinolytic mediator, tissue plasmino-
gen activator (t-PA) from the vascular endothelium. t-
PA antigen concentrations were determined in blood
samples collected before the first and following each
dose of bradykinin, using enzyme-linked immunosorbent
assay (TintElize tPA, Biopool EIA, Trinity Biotech, Bray,
Ireland).
Blood cell counts
Venous blood samples for blood cell counts were ob-
tained pre-exposure and 2, 4, 8 and 24 h post-exposure
and analyzed at an accredited hospital laboratory.
Assessing platelet activation with flow cytometry
Platelet activation was assessed using flow cytometry at
2 and 4 h post-exposure. Whole blood samples were im-
mediately labeled with monoclonal antibodies (mAbs)
for flow cytometric analysis: CD14-conjugated phyco-
erythrin (PE) (DAKO, Glostrup, Denmark) specific for
monocytes, fluorescein isothiocyanate (FITC)-conjugated
CD42a (Serotec, Oxford, UK) specific for platelets and
isotype-matched control (Serotec, Oxford, UK). CD14-
FITC and CD40-PE (Serotec, Oxford, UK) were used for
analysis of CD40 positive monocytes. After incubation,
cells were fixed and lysed with FACS-Lyse solution (Bec-
ton Dickinson, Franklin Lakes, New Jersey, USA) and
samples were analyzed using Facs Calibur flow cyt-
ometer (Becton Dickinson, Franklin Lakes, New Jersey,
USA). Platelet-monocyte aggregation and CD40 positiv-
ity of monocytes were expressed as percentage of 2000–
2500 collected monocytes. In addition, to determine
platelet surface expression of P-selectin and CD40-
ligand, whole blood was labeled with CD42a (FITC),
CD62p (PE) specific for P-selectin, CD154 specific for
CD40 Ligand and isotype controls. Cells were analyzed
with a Facs Calibur flow cytometer. Expression of P-
selectin and CD40L were expressed as percentage of col-
lected number of platelets (7500).
Respiratory measures
Forced expiratory volume during first second (FEV1) and
vital capacity (VC) were measured at baseline and 8 h post-
exposure by spirometry (Jaeger Masterlab, Carefusion, San
Diego, California) according to ATS/ERS guidelines (56).
Fraction of exhaled NO (FENO) concentrations were evalu-
ated using a nitric oxide analyzer (NIOX®, Aerocrine AB,
Stockholm, Sweden) at an exhalation rate of 50mL/s (±
10%), FENO50. Lung function measurements post-exposure
were performed at 8 h based on findings from preceding
studies as well as logistic aspects. As vascular measure-
ments were prioritized in the current study lung function
was mainly included to rule out major respiratory effects.
Data analysis and statistics
Based on our previous studies of endothelial vasomotor
function and endogenous fibrinolysis, to detect a 20%
difference in forearm blood flow and a 16% difference in
t-PA release, we require sample sizes of n = 16 at 80%
power and two-sided P < 0.05. Statistical analyses were
performed with GraphPad Prism (version 5, GraphPad
Software, La Jolla, California, USA). Data were analyzed
using paired and unpaired Student’s t-test, Wilcoxon
signed rank test and repeated measures analysis of vari-
ance (ANOVA), as appropriate. For blood cell counts,
post-exposure changes from baseline were calculated at
individual level. Statistical significance was taken at 2-
sided p < 0.05.
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